The emergence of Lyme disease and other tick-borne diseases

Fish, Durland

Talk: The emergence of Lyme disease and other tick-borne d... (22 min)

We hope you have enjoyed this limited-length demo talk

Would you like to recommend that your librarian or other responsible officer takes out a subscription to The Biomedical & Life Sciences Collection?
Would you like to apply for a free trial of the entire Biomedical & Life Sciences Collection?

Recommend to Librarian Apply for Free Trial Replay Talk

| more

Printable Slide Handouts PDF

DETAILED SLIDE INDEX

1. Introduction
2. Ticks
3. Tick vectors of lyme disease
4. Distribution of lyme disease vectors
5. lxodes ricinus / Ixodes persulcatus distribution
6. Ixodes scapularis
7. Ixodes scapularis life cycle
8. Collecting host-seeking ticks
9. Host seeking phenology (1)
10. Host seeking phenology (2)
11. Pathogen maintenance
12. Synchronous host seeking of nymphs
13. The nymphal stage
14. First description of lyme disease
15. The communities involved
16. Field study of ticks
17. The agent of lyme disease
18. Borrelia burgdorferi
19. Order: Spirochaetales, genus: Borrelia
20. Relapsing fever and lyme disease Borrelia
21. Geographic distribution of Borrelia burgdorferi
22. Borrelia burgdorferi pathogenic species
23. Genetic analysis (1)
24. Genetic analysis (2)
25. Genetic analysis (3)
26. Current distribution of Borrelia burgdorferi
27. Re-forestation of the northeast
28. Deer hunting was introduced
29. Reforestation, deer and lyme disease
30. Ixodes scapularis routes of expansion
31. Ixodes scapularis distribution in northeastern US
32. Source of infection for ticks
33. Other reservoir hosts
34. Nymphal infection prevalence
35. Tick infection prevalence data
36. Canines with antibody to Borrelia burgdorferi
37. Reported cases of lyme disease 1982-2007 (1)
38. Ixodes scapularis
39. Pathogen prevalence Ixodes scapularis nymphs
40. Ixodes scapularis feeds on humans
41. Emergence of human anaplasmosis
42. Current phylogeny and taxonomic classification
43. Anaplasma phagocytophilum
44. Anaplasma phagocytophilum prevalence
45. Anaplasmosis cases reported to CDC
46. Canines with antibody to A. phagocytophilum
47. Babesiosis emergence in Connecticut
48. Babesia microti
49. Phylogenetic analysis of Babesia microti
50. Transfusion-transmitted babesiosis
51. Emergence of powassan - deer tick virus
52. Powassan virus
53. Phylogeny of North American powassan virus
54. Transmission cycles
55. Fatal case of deer tick virus encephalitis
56. Research paper on relapsing fever spirochetes
57. Relapsing fever spirochetes
58. Spirochetes in SCID mouse blood
59. Prevalence of B. miyamotoi
60. Reported cases of lyme disease 1982-2007 (2)
61. Summary
62. Research team
63. Research sponsors
64. END

View Full Listing

RELATED TALKS

Play 'Similarities between prion diseases and other neurodegenerative diseases'

Prof. John Hardy

TOPICS COVERED IN THIS TALK

Pathology of diseases
Prion diseases
The first family with a prion mutation: Creutzfeldt-Jacob disease
Alzheimer's disease
7Mb duplication of locus around APP
APP probably a locus for "sporadic" Alzheimer's disease
Diseases with only Lewy bodies: Parkinson's disease and Lewy body dementia
Iowa kindred structure
alpha-synuclein
Diseases with only Tau pathology
The microtubule associated protein tau

Evolution of human tau haplotypes
Tagging SNPs selection
More complex than just H1/H2
Association with PSP is driven by H1c allele
Primary tauopathies
"Prion-like " behaviour of A-beta
Does the "spreading" of diseases reflect a less extreme version of infection?
Alzheimer's disease is a neuroanatomical disease which "spreads"
Parkinson's disease pathology also seems to spread
MAPT and alpha-synuclein in the extracellular compartment?

Papillomaviruses and HPV Vaccination to Prevent Cervical Cancer and other HPV-associated Diseases

Dr. Douglas Lowy

TOPICS COVERED IN THIS TALK

Cervical cancer is attributable to multiple HPV types; HPV16 predominates
Cervical cancer: time line of cervical HPV infections, progression and natural history
Key features of HPV pathogenesis
Challenges to development of a preventive HPV vaccine
A prophylactic vaccine
Formation of papillomavirus virions
Two distinct HPV VLP vaccines are under commercial development
Partial crossprotection against incident infection by other high risk HPV types

Overall efficacy in preventing HPV cervical disease attributable to incident infection
HPV life cycle
How could IM injection of a VLP vaccine prevent mucosal or cutaneous infection at the cervix?
Outstanding medical issues
Regulatory status of HPV VLP vaccines
Pap smear screening without vaccination would prevent more cervical cancer deaths than HPV16/18 vaccination without pap screening
Limitations of current VLP vaccines

Patient stratification for drug treatment in oncology and other diseases

Dr. Tim Harris

TOPICS COVERED IN THIS TALK

Personalised medicine in Oncology
Patient stratification using molecular markers
Next generation genome sequencing and data handling
Drivers of patient stratification including payors
Molecular profiling in lung and breast cancer
Relevance of these approaches for ALS, MS and other neurological diseases

The management of other aspects of chronic liver disease, including transplantation

Prof. Timothy M. McCashland

TOPICS COVERED IN THIS TALK

Common complications of end stage cirrhosis including life threatening disorders of variceal bleeding, ascites, hepatorenal syndrome, encephalopathy and hepatopulmonary syndrome
Preparation for listing for liver transplantation in patients with end stage liver disease includes documentation and absence of alcohol consumption (in alcoholics), reduction of hepatitis B DNA levels (in HBV patients) and aggressive treatment of hepatocellular carcinoma to reduce the risk of recurrent disease
The most common allocation system for liver transplantation is the model for end stage liver disease
Post transplantation care of the patient requires diligent annual followup with concentration on common diseases which include: metabolic syndrome (diabetes mellitus, obesity, hypertension, hyperlipidemia), Preventive medicine (vaccination, dental disease), Inflammatory bowel disease, bone disease, and renal dysfunction

Prion Diseases

Prof. Pierluigi Gambetti

TOPICS COVERED IN THIS TALK

Normal function of prion protein
Prion diseases
Mechanism of propagation of PrP
Propagation in acquired and familial forms
Pathogenic hypothesis
Human pathogenic mutation and polymorphisms

Laboratory methods
Epidemiology
Sporadic prion diseases
New variant CJD
Treatment of prion disease

TALK'S CITATION

Fish, D. (2011), "The emergence of Lyme disease and other tick-borne diseases", in Edman, J. (ed.), Vector-Borne Diseases: Characterization and epidemiology of arthropod transmitted infections, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at http://hstalks.com/bio)

RELATED SERIES

Genetics of Cardiovascular Disease
Genetic interactions in a multifactorial disease

Alzheimer's Disease
Neurobiology, pathology and treatment

Calcium Signaling II
Calcium and Disease

Molecular Chaperones
Principles and Diseases

Gene-Environment Interactions
Role in the Modulation of Pulmonary and Autoimmune Disease Risks

Welcome, Guest
Login

Apply for Free Trial Recommend to Librarian Keep Me Updated

ABOUT THIS TALK

Speaker(s)

Prof. Durland Fish

SPEAKER BIOGRAPHY

Prof. Durland Fish – Yale University Medical School, USA

Professor Fish conducts research on vector-borne diseases and directs the Center for EcoEpidemiology at Yale. He received his Ph.D. in Entomology and Ecology from the University of Florida and has held previous faculty positions at Fordham University and New York Medical College. His current research focuses on the ecology of tick-borne pathogens which cause Lyme disease and babesiosis.

Publication Date

August, 2011

Topics Covered

Expansion of the vector tick population North America due to environmental change... more

TOPICS COVERED IN THIS TALK

Expansion of the vector tick population North America due to environmental change
Mutual expansion of the spirochetal agent of Lyme disease alongside tick expansion
Agents of other human diseases are following
Babesiosis
Anaplasmosis
Flaviviral encephalitis
Other diseases

Series

Vector-Borne Diseases

OTHER TALKS IN THIS SERIES

GENERAL BACKGROUND

1. Overview of Arthropods & Their Impact on the Health of Humans & Other Vertebrates - Part 1

Prof. William S. Romoser

TOPICS COVERED IN THIS TALK

Arthropod significance, characteristics, classification and identification
Direct (e.g. blood-feeding) and indirect encounters between humans, animals and arthropods
Arthropods can be direct causes of pathology (e.g. stinging), facilitators of secondary infection and mechanical or biological vectors (transmitters) of pathogens
Mosquito blood-feeding and pathogen transmission provides a useful example of biological transmission

2. Overview of Arthropods & Their Impact on the Health of Humans & Other Vertebrates - Part 2

Prof. William S. Romoser

TOPICS COVERED IN THIS TALK

Both mandibulate and chelicerate arthropods can impact human and animal health
The most problematic mandibulates are insects, including cockroaches, lice, blood-feeding true bugs, fleas, true flies, ants, bees, and wasps
Among the chelicerates, mites & ticks, spiders and scorpions are of importance
Mites and ticks as vectors (transmitters) of pathogens and pests
Spiders and scorpions as venomous biters and stingers

3. Myiasis in humans and other animals, including applied applications in larval therapy & forensic entomology

Dr. Jamie Stevens

TOPICS COVERED IN THIS TALK

Typical larval infestations
The importance of myiasis-causing flies
Defining myiasis
Classification of myiasis
Blowflies and screwworm flies
Comparison of blowfly lifecycles
Economic impact of myiasis
Furuncular & Sanguinivorous larvae
Flesh flies: Sarcophagidae
Bot and warble flies: Oestridae

Other flies and the rat-tailed maggot
Evolution of parasitism in myiasis-causing flies & of myiasis
Breeding strategies influencing myiasis control
Myiasis control: traps, targets and insecticides
Disease ecology
Distribution of New World screwworm fly
SIT programme in North and Central America
Climate data, models and control
Larval therapy

4. Reactions to arthropod allergens, toxins and venoms

Prof. Stephen Wikel

TOPICS COVERED IN THIS TALK

Host responses to blood feeding arthropods
Skin reactions to bites, stings and contact
Mechanisms of reactions
Molecules responsible for reactions
Characterization of salivary gland gene expression and bioactive molecules in blood feeding arthropod saliva
Blood feeding arthropod modulation of host defenses

5. Parasite Transmission by Arthropods

Prof. William K. Reisen

TOPICS COVERED IN THIS TALK

Parasite acquisition, mouthparts and blood feeding
Modes of parasite replication and transmission in the arthropod and vertebrate hosts
Factors affecting the efficiency of transmission
Role of humans: anthroponoses vs zoonoses
Intrinsic and extrinsic incubation

6. Mechanical transmission or dissemination of infectious pathogens/parasites by arthropods

Prof. Lane Foil

TOPICS COVERED IN THIS TALK

Definition of types of transmission of agents of disease by arthropods
Indirect mechanical transmission of different agents and by different vectors
Direct mechanical transmission of different agents and by different vectors
Arthropod feeding behavior relative to transmission of different agents
Factors affecting the probability of mechanical transmission events
Ways to reduce the probability of mechanical transmission events

7. Epidemiology of vector-borne diseases

Dr. Laura C. Harrington

TOPICS COVERED IN THIS TALK

Introduction to the field of epidemiology
Determinants of disease
Epidemiological measures
Field based epidemiology of vector-borne diseases

8. Surveillance, prevention and control of vector-borne infections

Prof. Jonathan Day

TOPICS COVERED IN THIS TALK

Vector-borne disease surveillance
Pathogen detection
Spatial distribution of vector-borne diseases
Temporal distribution of vector-borne diseases
Measurement of vector-borne disease transmission risk
Vector-borne disease prevention
Vector avoidance, vector control, and disease control

9. GIS, Remote Sensing and Spatial Analysis for Vector-borne Diseases

Prof. Uriel Kitron
Dr. Gonzalo Vazquez-Prokopec

TOPICS COVERED IN THIS TALK

Spatial aspects in surveillance and research
Tools for spatial analysis
Spatial statistics
Landscape ecology
Scale and resolution
Risk maps
Three examples: West Nile Virus in Chicago, Chagas disease in Argentina and Dengue in Australia
Opportunities and limitations

ARTHROPOD-BORNE VIRAL DISEASES (THE ARBO VIRUSES)

10. Dengue and Yellow Fever: the Anatomy of Decline and Emergence

Prof. Duane J. Gubler

TOPICS COVERED IN THIS TALK

Dengue and Yellow Fever virus, are both Flaviviruses
Epidemiology and transmission cycles
History
Effective control
Re-emergence of epidemic dengue as global public health problem
Reasons for emergence
Threat of Yellow Fever as an emerging epidemic disease

11. The Bunyaviridae

Prof. Laura D. Kramer

TOPICS COVERED IN THIS TALK

Bunyaviridae family: basic biology, classification, vector and disease associations, viral structure, basic replication strategy
Specific arthropod-borne genera in the Bunyaviridae family, i.e. Bunyavirus, Phlebovirus, Nairovirus: transmission cycles and prevalence

12. Vector-borne Alpha virus infections

Prof. Scott Weaver

TOPICS COVERED IN THIS TALK

Overview of the alphaviruses
Systematics and evolution
Structure and replication
Disease and pathogenesis
Diagnosis, control and prevention of disease

VECTOR-BORNE BACTERIAL/RICKETTSIAL DISEASES

13. The emergence of Lyme disease and other tick-borne diseases

Prof. Durland Fish

Now Playing

14. Plague and other flea-borne infections

Prof. Kevin S. Griffith

TOPICS COVERED IN THIS TALK

Overview of fleas
Background and epidemiology of plague
Clinical aspects of plague, including manifestations, diagnostics, and treatment
Control and prevention of plague
Other flea-borne infections

15. Epidemic typhus and other louse- and mite-borne infections

Dr. Kevin Macaluso

TOPICS COVERED IN THIS TALK

Louse characteristics including biology, taxonomy and species of medical importance
Louse-borne infections
Ecology and epidemiology of epidemic typhus, trench fever and relapsing fever
Mite characteristics including biology, taxonomy, and species of medical importance
Mite-borne infections
Ecology and epidemiology of rickettsialpox and scrub typhus

VECTOR-BORNE PROTOZOAN DISEASES

16. Malaria in the mosquito

Prof. Peter Billingsley

TOPICS COVERED IN THIS TALK

Malaria: one of the world's foremost killers
Malaria in the mosquito
The mosquito midgut -- Exflagellation
Ookinetes
Antibodies block transmission to mosquito
CTRP KO results in loss of infectivity to mosquito
The time bomb theory of ookinete invasion

Oocysts
Interactions between Plasmodium and mosquito midgut
Insect immunity
Sporozoites
A sporozoite based malaria vaccine
Dynamics of Malaria in the mosquito

17. Species complexes: confusion in identifying the true vectors of malaria and other parasites

Prof. Susan Paskewitz

TOPICS COVERED IN THIS TALK

History and the anopheline mosquito species complexes
Methods of identification of species complexes (behavioral, genetic, chromosomal)
Molecular tools for diagnosis of species
Evolution of species complexes
Ecological and ecotypic speciation

18. Tsetse fly-transmitted African Trypanosomiasis

Prof. Mike Lehane

TOPICS COVERED IN THIS TALK

Sleeping sickness and nagana
Major treatments
Shortcomings of current treatment regimes and why vector control is important
Introduction to tsetse biology
Primary methods of tsetse fly control

19. Triatominae Vectors of Chagas disease

Prof. Christopher J. Schofield

TOPICS COVERED IN THIS TALK

History of Chagas disease including incidence, prevalence and economic impact
Classification, biology and ecology of Triatominae
Role as vectors
Population dynamics
Population genetics
Chagas disease control initiatives including background, progress and challenges

VECTOR-BORNE FILARIAL DISEASES

20. The Biology and Control of Human Onchocerciasis

Prof. Ed Cupp

TOPICS COVERED IN THIS TALK

Onchocerca volvulus distribution, pathology, development and vector transmission
Early control strategies for human onchocerciasis
Emergence of ivermectin (Mectizan(R)) for therapy and control
Development of regional control programs
Summary of progress and needs

21. Lymphatic Filariasis

Prof. David H. Molyneux

TOPICS COVERED IN THIS TALK

Lymphatic Filariasis as a disabling, mosquito-borne parasitic disease
Control strategies through annual drug therapy
Control of vector mosquitoes
The progress in the Global Programme; mapping, monitoring, evaluation, pathology, morbidity management
Multiple benefits of drugs in other conditions